Our community outreach initiatives continue to expand and broaden our reach. With nearly 300 community events scheduled for this year, in addition to several major fundraisers, we are propelled forward by the momentum, spirit and dedication of our volunteers who make these events possible.
This momentum extends to our nationwide Pancreatic Cancer Research Walk program as well, which features 36 walks this year, including inaugural walks in Butler County, OH; Colorado Springs, CO; El Paso, TX; Hannibal, MO; Louisville, KY; Newport News, VA; and Silicon Valley, CA. Our walk series has raised $35 million to date in our quest to advance new treatments and develop early detection techniques. We could not be more grateful to our teams, walkers and volunteers from our patient community who join us and help the walk program raise substantial research funding.
The Lustgarten Foundation hosts a Mission Tent at each walk, staﬀed by trained volunteers. In this tent, patients and their families can access the up-to-date information they need to make informed healthcare decisions, ﬁnd the latest news in pancreatic cancer research, and learn about other opportunities to engage with fellow patients. Additionally, pancreatic cancer survivors are invited to participate in a ribbon-cutting ceremony to oﬃcially start each walk.
Let's Win: Sharing Science Solutions for Pancreatic Cancer
, an initiative supported by The Lustgarten Foundation and launched in May, is an interactive online community where patients and families can share information and experiences about new, innovative science-driven treatments and learn about the latest research, breakthroughs, and clinical trials in the ﬁght against pancreatic cancer. The cornerstone of Let’s Win is the interactive My Treatment section where patients describe their personal treatment plans, focusing on novel and innovative treatments they have pursued beyond the standard of care. Patients can learn from others who have tried other treatment options and can share this information with their doctors to explore emerging therapies.